CD44 and glioma: Although the mechanism of action is not fully understood, galangin has been shown to inhibit endothelial cell migration and angiogenesis by downregulating CD44, a multifunctional cell surface glycoprotein which is over expressed in glioma (brain cancer) (Chen et al., 2019).